ROR1 and endometriosis: Initial functional evaluation was conducted using the 2D endometriosis cell line 12Z to screen three candidate repurposed agents, rimegepant, cabergoline, and pirenzepine, identified through the computational ROR1-binding prioritization pipeline and selected through consumer and clinician input.